China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Study on Jiagliflozin for Improving Urinary Albumin and Inflammation in Patients with Diabetic Nephropathy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135827
Registration Time: 2026/11/02
Type: Interventional study
Primary Sponsor: Xiaoyi Central Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349329
Published by HT Digital Content Services with permission from Health Daily Digest....